Press Release

SIXTH U.S. PATENT AWARDED TO SRU BIOSYSTEMS
Broad Methods and Compositions for Optical Detection; Use of Labels is Not Required

Woburn, Massachusetts, September 12, 2006 -- SRU Biosystems, Inc. (“SRU” or “the Company”) announced today that U.S. Patent 7,094,595 (“the ‘595 patent”), entitled “Label-Free High-Throughput Optical Technique for Detecting Biomolecular Interactions” was issued to SRU Biosystems on August 22, 2006.

“The ‘595 patent extends a string of foundational patents issued to SRU over the past several months,” stated Owen Dempsey, CEO of SRU Biosystems. “We believe this once again demonstrates the broad and foundational nature of BIND™. It extends and solidifies the strong, intellectual property position of SRU in optical, label-free detection.”

SRU’s growing intellectual property portfolio encompasses all aspects of the Company’s BIND™ system, which the Company believes sets the standards in label-free detection. Mr. Dempsey continued, “We want to concentrate on commercializing our BIND™ Biosensor product line. From proteins to small molecules and cells; from plate-based screening to microarray applications, BIND™ is an exciting tool for the future of drug discovery.”

SRU Biosystems, Inc., is a life science company developing novel technologies for rapidly analyzing the interactions of cells, proteins, genomic, peptide, antibody or small molecule compound libraries against a wide range of biochemical targets. The BIND™ Biosensor technology represents a fundamental advance in the ability to monitor label-free biochemical interactions with high sensitivity and high throughput. SRU is incorporating its technology into microtiter plates, microarray slides and other industry standard formats to create sensitive and high throughput tools that can be used to answer important biological questions for biomedical research, pharmaceutical drug discovery and diagnostic.